Jeena Sikho Lifecare Limited has informed the Exchange about Publication of Case Studies and Case reports.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare Limited has announced the publication of 7 academic papers — 5 case studies and 2 case reports — in three peer-reviewed journals: the International Journal of Ayurveda and Herbal Research, the Journal of Applied Science and Education, and the European Journal of Pharmaceutical and Medical Research. The papers cover Ayurvedic treatment approaches for conditions like Polycystic Ovarian Disease, kidney disorders (Vrikka Roga/CKD), colon ulcer, and cervical spondylosis (Grivastambha). The publications have been authored by medical professionals associated with the company, including Managing Director Manish Grover, senior consultants, and Ayurvedic experts. The company has filed this under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The company says this reflects its continued commitment to advancing Ayurvedic research and promoting evidence-based clinical practices.
This is a brand-building and research credibility announcement rather than a material financial event, so it is unlikely to cause an immediate significant move in the stock price. However, it may help strengthen the company's positioning in the Ayurvedic healthcare segment and build long-term trust with patients and stakeholders.